Avidity biosciences announces upcoming presentations at 2023 mda clinical & scientific conference

San diego , march 13, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that the company will be presenting two oral presentations and multiple poster presentations at the 2023 mda clinical & scientific conference in dallas, texas, being held march 19-22, 2023. oral presentations      march 22, 2023: 10:30 a.m.
RNA Ratings Summary
RNA Quant Ranking